1. Home
  2. NSP vs VCEL Comparison

NSP vs VCEL Comparison

Compare NSP & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insperity Inc.

NSP

Insperity Inc.

HOLD

Current Price

$53.46

Market Cap

2.0B

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$40.95

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSP
VCEL
Founded
1986
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.4B
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
NSP
VCEL
Price
$53.46
$40.95
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$47.67
$57.75
AVG Volume (30 Days)
446.5K
461.2K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
6.45%
N/A
EPS Growth
N/A
60.00
EPS
0.97
N/A
Revenue
$6,812,000,000.00
$276,259,000.00
Revenue This Year
$3.45
$19.40
Revenue Next Year
$6.95
$18.24
P/E Ratio
$53.41
N/A
Revenue Growth
3.51
16.45
52 Week Low
$18.57
$28.95
52 Week High
$57.22
$49.32

Technical Indicators

Market Signals
Indicator
NSP
VCEL
Relative Strength Index (RSI) 59.58 35.71
Support Level $47.54 $35.45
Resistance Level $55.09 $42.16
Average True Range (ATR) 2.35 1.42
MACD -0.24 -0.36
Stochastic Oscillator 88.80 8.83

Price Performance

Historical Comparison
NSP
VCEL

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: